Silvercrest Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Sell
257,228
-2,169
-0.8% -$250K 0.22% 123
2025
Q4
$27.3M Sell
259,397
-3,733
-1% -$350K 0.19% 149
2025
Q3
$22.1M Sell
263,130
-604
-0.2% -$49.7K 0.15% 188
2025
Q2
$20.9M Sell
263,734
-398
-0.2% -$31.6K 0.14% 194
2025
Q1
$23.7M Sell
264,132
-24,784
-9% -$2.31M 0.17% 162
2024
Q4
$28.7M Sell
288,916
-12,107
-4% -$1.25M 0.19% 147
2024
Q3
$34.2M Buy
301,023
+192
+0.1% +$22.8K 0.23% 133
2024
Q2
$37.2M Sell
300,831
-5,048
-2% -$650K 0.26% 131
2024
Q1
$40.4M Sell
305,879
-31,939
-9% -$3.94M 0.27% 124
2023
Q4
$36.8M Sell
337,818
-673
-0.2% -$69.9K 0.26% 127
2023
Q3
$34.8M Sell
338,491
-2,349
-0.7% -$253K 0.26% 123
2023
Q2
$39.3M Sell
340,840
-435
-0.1% -$49.4K 0.28% 122
2023
Q1
$36.3M Sell
341,275
-3,908
-1% -$422K 0.28% 123
2022
Q4
$38.3M Sell
345,183
-2,686
-0.8% -$275K 0.29% 116
2022
Q3
$30M Sell
347,869
-13,405
-4% -$1.2M 0.25% 128
2022
Q2
$32.9M Buy
361,274
+10,630
+3% +$942K 0.25% 135
2022
Q1
$28.8M Sell
350,644
-4,032
-1% -$318K 0.19% 151
2021
Q4
$27.2M Sell
354,676
-8,128
-2% -$647K 0.17% 152
2021
Q3
$27.3M Sell
362,804
-30,385
-8% -$2.31M 0.18% 151
2021
Q2
$30.6M Sell
393,189
-22,583
-5% -$1.68M 0.2% 149
2021
Q1
$30.6M Sell
415,772
-4,080
-1% -$301K 0.21% 145
2020
Q4
$32.8M Sell
419,852
-10,178
-2% -$778K 0.24% 130
2020
Q3
$34M Sell
430,030
-8,890
-2% -$696K 0.29% 114
2020
Q2
$32.4M Buy
438,920
+11,828
+3% +$890K 0.29% 114
2020
Q1
$31.4M Sell
427,092
-16,866
-4% -$1.33M 0.34% 96
2019
Q4
$38.5M Sell
443,958
-9,919
-2% -$815K 0.3% 110
2019
Q3
$36.5M Sell
453,877
-475
-0.1% -$38.1K 0.3% 114
2019
Q2
$36.4M Sell
454,352
-2,069
-0.5% -$158K 0.34% 119
2019
Q1
$36.2M Sell
456,421
-7,058
-2% -$528K 0.36% 115
2018
Q4
$33.8M Sell
463,479
-12
-0% -$847 0.37% 113
2018
Q3
$31.4M Sell
463,491
-12,221
-3% -$779K 0.28% 126
2018
Q2
$27.6M Sell
475,712
-11,475
-2% -$647K 0.26% 127
2018
Q1
$25.3M Sell
487,187
-5,026
-1% -$271K 0.25% 130
2017
Q4
$26.4M Buy
492,213
+3,051
+0.6% +$169K 0.25% 128
2017
Q3
$29.9M Buy
489,162
+570
+0.1% +$34.6K 0.3% 117
2017
Q2
$29.9M Sell
488,592
-8,954
-2% -$545K 0.32% 112
2017
Q1
$30.2M Sell
497,546
-8,715
-2% -$529K 0.32% 106
2016
Q4
$28.4M Sell
506,261
-8,943
-2% -$523K 0.32% 106
2016
Q3
$30.7M Sell
515,204
-4,066
-0.8% -$238K 0.37% 99
2016
Q2
$28.5M Buy
519,270
+1,108
+0.2% +$59K 0.36% 101
2016
Q1
$26.2M Sell
518,162
-11,532
-2% -$565K 0.36% 101
2015
Q4
$26.7M Buy
529,694
+150,587
+40% +$7.59M 0.37% 98
2015
Q3
$17.9M Sell
379,107
-167,631
-31% -$8.9M 0.27% 111
2015
Q2
$29.7M Buy
546,738
+161,028
+42% +$9.03M 0.4% 101
2015
Q1
$21.2M Buy
385,710
+3,409
+0.9% +$193K 0.3% 108
2014
Q4
$20.7M Buy
382,301
+4,345
+1% +$242K 0.3% 108
2014
Q3
$21.4M Sell
377,956
-1,514
-0.4% -$85K 0.33% 99
2014
Q2
$20.9M Buy
379,470
+2,240
+0.6% +$122K 0.31% 105
2014
Q1
$20.4M Sell
377,230
-8,000
-2% -$414K 0.33% 104
2013
Q4
$18.4M Sell
385,230
-436,271
-53% -$19.9M 0.31% 108
2013
Q3
$37.3M Sell
821,501
-506,403
-38% -$23.1M 0.72% 48
2013
Q2
$58.9M Buy
+1,327,904
New +$59.3M 1.24% 15

Other funds holding MRK

Silvercrest Asset Management's MRK Position: Q1 2026 in Review

Silvercrest Asset Management reduced its Merck (MRK) stake by 0.84% in Q1 2026, selling an estimated $250K and leaving 257,228 shares worth $30.9M. The position accounts for 0.22% of the portfolio, ranked #123.

Silvercrest Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.9M in Q2 2013. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Silvercrest Asset Management held 257,228 shares of Merck worth $30.9M as of Q1 2026.
  • Silvercrest Asset Management sold 2,169 Merck shares in Q1 2026, an estimated $250K.
  • Merck made up 0.22% of Silvercrest Asset Management's portfolio in Q1 2026, its #123 holding.
  • Silvercrest Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Silvercrest Asset Management's Merck position peaked at $58.9M in Q2 2013.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.